Welcome to our dedicated page for Orthofix Med news (Ticker: OFIX), a resource for investors and traders seeking the latest updates and insights on Orthofix Med stock.
Orthofix Medical Inc. (NASDAQ: OFIX) is a global medical technology company headquartered in Lewisville, Texas, with a focus on musculoskeletal care. The Orthofix news stream highlights developments across its spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including updates related to the 7D FLASH™ Navigation System.
Investors and healthcare professionals following Orthofix news can review regular earnings announcements, where the company reports net sales and segment performance for Bone Growth Therapies, Spinal Implants, Biologics and Enabling Technologies, Global Spine and Global Orthopedics. These releases often include commentary on trends in U.S. Spine Fixation, bone growth therapy performance, and the progress of its orthopedics business focused on limb reconstruction.
News coverage also features regulatory and product milestones, such as FDA 510(k) clearance and CE Mark for the TrueLok™ Elevate Transverse Bone Transport System and the global commercial launch of TrueLok Elevate. Orthofix uses these announcements to describe how TrueLok Elevate fits into its TrueLok family of multiplanar external fixators and supports limb preservation and diabetic wound-related treatment needs.
In addition, Orthofix issues releases about upcoming investor conference appearances and the timing of quarterly financial results and conference calls. For anyone tracking OFIX, this news page provides a centralized view of the company’s public communications on financial performance, product launches, regulatory clearances and investor events.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Orthofix Medical Inc. (NASDAQ:OFIX) will release its first quarter 2023 financial results on May 9, 2023, after market close. A conference call to discuss these results will take place at 4:30 p.m. ET on the same day, with access details available for interested parties. The newly merged Orthofix-SeaSpine organization is recognized as a leader in the global spine and orthopedics sector, offering a diverse range of products distributed across approximately 68 countries. The company is headquartered in Lewisville, Texas, and maintains a focus on innovation in spine and biologics products, with significant presence across multiple locations including California and Europe.
Orthofix Medical Inc (NASDAQ: OFIX) announced the full commercial launch of two innovative access retractor systems, the Lattus™ Lateral Access System and the Fathom™ Pedicle-Based Retractor System, aimed at enhancing minimally invasive spine (MIS) surgeries, targeting a market valued at approximately $1.8 billion.
The Lattus system emphasizes user-friendliness and versatility, improving access and procedural efficiency for spine surgeries. Meanwhile, the Fathom system allows for precise control over blade adjustments, enhancing surgical outcomes. Both systems are designed to integrate seamlessly with Orthofix's existing products, demonstrating the company's commitment to delivering comprehensive solutions in the operating room.